Steel Partners has made an unsolicited acquisition offer for InMode at $16.75 per share in cash, valuing the RF microneedling and radiofrequency device manufacturer at a significant premium to recent trading levels. The bid underscores ongoing consolidation among aesthetic-device OEMs as private equity seeks to build larger platforms and capture recurring revenue from installed bases.
Business & M&A
Steel Partners Offers $16.75 Per Share for InMode—Device Consolidation Accelerates
PE-backed buyout bid for RF microneedling and energy-device maker signals continued roll-up activity in the aesthetic-device space.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
$16.75 per share—and Steel Partners is just one bidder. Device consolidation is reshaping the competitive landscape.
InMode's core products—Fractora (fractional RF microneedling) and Lumenis-legacy RF systems—generate strong unit economics and high attach rates for consumables and service contracts. A PE acquisition typically means aggressive cost-cutting, accelerated international expansion, and pressure to cross-sell across a broader device portfolio. For practices, this matters: ownership changes often trigger rebate restructuring, sales-force turnover, and shifts in clinical support priorities. The board's evaluation of "rival offers" suggests competing bidders are circling, which could push the final price higher.
Source: original report ↗
Frequently asked questions
What does the Steel Partners acquisition of InMode mean for medspa owners?
PE ownership typically triggers rebate restructuring, sales-force turnover, and shifts in clinical support priorities. Practices should expect potential changes to pricing, service levels, and the availability of consumables and support contracts for InMode devices like Fractora and RF systems.
Will InMode device prices go up or down after a private equity buyout?
PE firms typically pursue cost-cutting and margin expansion, which can lead to rebate restructuring and higher consumable costs for practices. While initial hardware pricing may stabilize, expect increased pressure on recurring revenue from service contracts and supplies.
What is Fractora and why does InMode's acquisition matter?
Fractora is InMode's fractional RF microneedling system, one of their core revenue drivers with strong unit economics and high attach rates for consumables. The acquisition signals continued consolidation in the aesthetic-device space as PE firms build larger platforms to capture recurring revenue from installed bases.
Could another company outbid Steel Partners for InMode?
Yes—InMode's board is evaluating rival offers, suggesting competing bidders are circling. This competitive bidding could push the final acquisition price higher than Steel Partners' initial $16.75-per-share offer.
How does device consolidation affect medspa competition?
Consolidation typically leads to aggressive international expansion and cross-selling across broader device portfolios, which can intensify competition in local markets. PE-backed platforms often prioritize high-volume practices and may shift clinical support away from smaller independent medspas.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.